By Fineline Cube 
Switzerland-based skin care specialist Galderma officially launched Sculptra in China this week, marking the first proven regenerative biostimulator available in the market. The product, featuring a unique poly-L-lactic acid (PLLA-SCA) formulation, received approval in China last year for correcting mid-facial volume loss and/or contour deficiencies.
Product Mechanism and Benefits
Sculptra works by stimulating the body’s natural processes to promote healthier, radiant skin and a more youthful appearance. Backed by over 25 years of clinical evidence and a strong safety profile, Sculptra’s approval in China was supported by local studies demonstrating high and sustained response rates in midface volume and contour correction for up to two years. Key benefits include volumization, improved skin firmness, structural support, enhanced radiance, overall skin quality, and natural-looking results.
Market and Consumer Impact
The launch of Sculptra in China addresses the growing demand for advanced aesthetic treatments that deliver long-lasting and natural results. With its regenerative properties, Sculptra offers a significant advancement in skin care, providing consumers with a safe and effective solution for mid-facial volume loss and contour deficiencies.-Fineline Info & Tech